Full Court upholds Sequenom’s win in patent battle over prenatal genetic tests
The Full Federal Court has upheld US biotech company Sequenom’s patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic’s argument that the patent merely described a way to extract incorporeal genetic information.
For information on rights and reprints, contact subscriptions@lawyerly.com.au